Want to join the conversation?
Jeff Holford with Jefferies asks about the ACV franchise, the ex-US sales over the next few quarters. $BMY said it has seen the maturation of its business in Japan. New competitive entrants have significantly reduced $BMY's performance there. In Europe, the company continues to sustain a very high penetration of the genotype 3 patient population.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.